Changes in Menopausal Hormone Therapy Use in Germany
Author Information
Author(s): Du Yong, Dören Martina, Melchert Hans-Ulrich W, Scheidt-Nave Christa, Knopf Hildtraud
Primary Institution: Robert Koch-Institute, Berlin, Germany
Hypothesis
To examine the differences in menopausal hormone therapy (MHT) use and user profiles among women in Germany before and after the communication of the Women's Health Initiative (WHI) trial.
Conclusion
Current MHT use considerably declined among women in Germany between the pre- and post-WHI era.
Supporting Evidence
- MHT use decreased by 40.2% from 16.9% in 1997-1999 to 10.1% in 2003-2004.
- The decline in MHT use was most pronounced among women aged 40-59.
- Higher social status was associated with higher MHT use in the earlier survey but not in the later one.
Takeaway
The number of women using hormone therapy for menopause dropped a lot in Germany after new research showed it might not be safe.
Methodology
Data from two national health surveys conducted in 1997-1999 and 2003-2004 were analyzed using multivariable logistic regression.
Potential Biases
Potential bias due to differences in survey methods and participant reporting.
Limitations
The study only captures data at two points in time and may not account for trends in between.
Participant Demographics
Women aged 40-79 years from Germany.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website